RedHill Biopharma is dedicated to the development and commercialization of proprietary, orally-administered, small molecule drugs for the treatment of gastrointestinal and inflammatory diseases, including cancer



Commercial Products

RedHill has assembled an experienced specialty GI commercial team, with a proven track-record, to lead its U.S. commercial operations and promote its two commercially-available gastrointestinal specialty products: 

Donnatal® (Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide) - a prescription oral adjunctive drug used in the treatment of IBS and acute enterocolitis.

EnteraGam® - a medical food intended for the dietary management of chronic diarrhea and loose stools


Development Pipeline 

RedHill's pipeline of  late-stage, proprietary development programs includes three Phase III programs for gastrointestinal disease, as well as several Phase II programs in oncology and gastrointestinal diseases.